Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IDXG

Interpace Biosciences (IDXG) Stock Price, News & Analysis

Interpace Biosciences logo

About Interpace Biosciences Stock (NASDAQ:IDXG)

Advanced Chart

Key Stats

Today's Range
$0.78
$0.78
50-Day Range
$4.75
$10.40
52-Week Range
$2.57
$10.42
Volume
1,111 shs
Average Volume
6,816 shs
Market Capitalization
$3.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Interpace Biosciences and its competitors with MarketBeat's FREE daily newsletter.

IDXG Stock News Headlines

PDI: Inflection Point Ahead
PDI: Nothing Special... Yet
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
PDI: Huge Income, But Please Know What You Own
PDI: A Decent Income Investment
PDI: An Opportunity To Lock In A 14% Yield On Cost
See More Headlines

IDXG Stock Analysis - Frequently Asked Questions

Interpace Biosciences, Inc. (NASDAQ:IDXG) issued its earnings results on Monday, November, 4th. The business services provider reported $0.31 earnings per share for the quarter. The business services provider had revenue of $12.30 million for the quarter. Interpace Biosciences had a negative trailing twelve-month return on equity of 8.09% and a net margin of 10.39%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Interpace Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Bristol Myers Squibb (BMY), Novavax (NVAX) and Histogenics (HSGX).

Company Calendar

Last Earnings
11/04/2024
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:IDXG
CIK
1054102
Employees
152
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$800 thousand
Pretax Margin
10.93%

Debt

Sales & Book Value

Annual Sales
$40.21 million
Cash Flow
$0.39 per share
Price / Cash Flow
1.99
Book Value
($14.16) per share
Price / Book
-0.06

Miscellaneous

Free Float
4,167,000
Market Cap
$3.44 million
Optionable
Not Optionable
Beta
0.76
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:IDXG) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners